ArticleAnnals of gastroenterological surgery2026
Efficacy of Sequential Hepatic Vein Embolization Following Portal Vein Embolization in Promoting Regeneration of Liver Volume and Function Before Right-Sided Major Hepatectomy.
Article in Annals of gastroenterological surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Response to "Sequential Portal Vein-Hepatic Vein Embolization: Progress Yet Unaccounted Pitfalls".Annals of gastroenterological surgery · 2026Article
- Sequential Portal Vein-Hepatic Vein Embolization: Progress Yet Unaccounted Pitfalls.Annals of gastroenterological surgery · 2026Article
Corrections and comments
- Commented on by
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/Purpose: This study compared the efficacy of sequential hepatic vein embolization (HVE) following portal vein embolization (PVE) with PVE alone in promoting both the volume and function of the future remnant liver (FRL) before right-sided major hepatectomy. Methods: All patients underwent preoperative PVE with or without sequential HVE, followed by right hepatectomy ± extended from 2018 to 2023. Changes in FRL volume and function were analyzed and compared between groups, with liver function assessed using technetium-99m diethylenetriaminepentaacetic acid-galactosyl-human serum albumin ( Results: Eight patients underwent sequential PVE-HVE, while 24 underwent PVE alone. All patients underwent embolization without severe complications. The median regeneration rate of FRL volume was significantly higher in the sequential HVE-HVE group at 35.5% (20.6%-54.0%) compared with 26.2% (19.2%-31.0%) in the PVE group ( Conclusions: Sequential PVE-HVE is safe and practical, leading to a significant increase in both the volume and function of the FRL.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.